FZB NeuesLogo 2017 Deutsch

Die Lunge im Fokus
Die Lunge im Fokus
Die Lunge im Fokus
Die Lunge im Fokus
die-lunge-im-fokus-fzb.jpg
Focus on the lungs
We are the lung research center of the Leibniz Association.
Our main focus: Common diseases such as asthma, allergies and chronic obstructive pulmonary disease (COPD), as well as infection-related inflammation of the lungs, in particular tuberculosis (TB).
Our Mission
die-lunge-im-fokus-fzb.jpg
Chronic lung diseases
The program area is dedicated to research into asthma, COPD and allergies, as these are among the most common chronic diseases and therefore cause an enormous burden for both patients and healthcare systems.
Priority Research Area
die-lunge-im-fokus-fzb.jpg
Infections
The Infections program area is dedicated to researching and combating bacterial infectious diseases of the lung with a focus on tuberculosis.
The aim is to improve the control and treatment of this disease.
To the program area
die-lunge-im-fokus-fzb.jpg
Science & Technology
This area combines overarching research units that are essential for research at the FZB and represent an important link between the subject areas.
Further Information
previous arrow
next arrow

News

  • calendar regular12.08.2025

    Herzlichen Glückwunsch! Dr. Nicolas Gisch hält Antrittsvorlesung an der Universität zu Lübeck

    Dr. Nicolas Gisch hat am 15. Juli die Antrittsvorlesung im Rahmen seiner Habilitation an der Universität zu Lübeck im Fachgebiet Biochemie gehalten. Der Titel der Vorlesung: "Virulenzfaktoren oder doch nur Dekoration? Die biologische Relevanz von Lipoteichonsäuren und Lipoglykanen Gram-positiver Bakterien"

  • calendar regular07.08.2025

    Hörtipp: Interview mit Prof. Uta Jappe zum Thema Fleischallergie

    Prof. Uta Jappe von Forschungszentrum Borstel, Leibniz Lungenzentrum beantwortet im Interview mit Martin Gramlich  in dem Format "Wissen aktuell - Impuls" vom Südwestrundfunk SWR warum Zeckenstiche eine Fleischallergie auslösen können.

  • calendar regular01.08.2025

    UNITE4TB flagship trial completes first wave recruitment

    Tuberculosis (TB) is a major threat to public health and is among the leading causes of death worldwide, according to the World Health Organization. The emergence of drug-resistant TB and current standard of long treatment regimens have increased the urgent need for new, more effective therapies. 

Prof. Dr. Frank Petersen

  • FG Gruppe_en: Pulmonary Immune Diseases

Contact

Prof. Dr. Frank Petersen
This email address is being protected from spambots. You need JavaScript enabled to view it.
+49 4537 / 188-4510
+49 4537 / 188-2091

Links

Events

  • Lipidomics Forum 2025

    calendar regular14. - 17. September 2025
    location dot solidUniversity Vienna, Institute of Analytical Chemistry, 1090 Vienna, Austria

  • Northern Germany Meeting on Infection, Immunology and Inflammation

    calendar regular08. Oktober 2025
    location dot solidBorstel

  • Antibiotics LC-MS/MS Quantitation - DZIF Online Course

    calendar regular16. Oktober 2025
    location dot solidonline